Bariatric Surgery as a Viable Treatment for Idiopathic Intracranial Hypertension: a Case Series and Review of Literature.
Bariatric surgery
Idiopathic intracranial hypertension
Preventable blindness
Sleeve gastrectomy
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
02
03
2021
accepted:
09
07
2021
revised:
26
06
2021
pubmed:
30
7
2021
medline:
26
10
2021
entrez:
29
7
2021
Statut:
ppublish
Résumé
Idiopathic intracranial hypertension is a significant cause of preventable blindness. Patients suffer from debilitating headaches, pulsatile tinnitus, nausea, vomiting, photophobia and radicular pain. At this rate, treatment cost will increase to 462.7 million pounds sterling annually by 2030. Weight loss is the only proven disease-modifying therapy for reversal of idiopathic intracranial hypertension. Bariatric surgery leads to superlative weight loss and reversal of related comorbidities. The case series and literature review aim to raise awareness of bariatric surgery as a safe and effective treatment modality for idiopathic intracranial hypertension. The literature review comprises three systematic analysis and one randomised control trial which were identified after a PubMed search. In the case series, we have included four patients with a preoperative diagnosis of long-standing idiopathic intracranial hypertension. They were referred to our department for bariatric surgery by the neuro-ophthalmologist between January and December 2018. They were followed up for 2 years after bariatric surgery. All four patients were women with a mean age of 34 years. Mean body mass index reduced from 47.3 kg/m Bariatric surgery is a safe and effective method of treating idiopathic intracranial hypertension. It is superior compared to medical management and cerebrospinal fluid pressure reducing procedures which have high rates of recurrence.
Identifiants
pubmed: 34322839
doi: 10.1007/s11695-021-05587-4
pii: 10.1007/s11695-021-05587-4
pmc: PMC8318322
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
4386-4391Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Lancet. 2011 Aug 27;378(9793):838-47
pubmed: 21872752
Lancet Neurol. 2016 Jan;15(1):78-91
pubmed: 26700907
Cephalalgia. 2011 Dec;31(16):1627-33
pubmed: 21968519
Brain. 1974 Jun;97(2):301-12
pubmed: 4434179
Can J Surg. 2020 Mar 20;63(2):E123-E128
pubmed: 32195557
Arch Ophthalmol. 1988 Oct;106(10):1365-9
pubmed: 3052381
Ophthalmology. 2017 May;124(5):697-700
pubmed: 28187976
Neurology. 2004 Oct 12;63(7):1314-6
pubmed: 15477563
Obes Surg. 2017 Feb;27(2):513-521
pubmed: 27981458
Neurology. 2002 Nov 26;59(10):1492-5
pubmed: 12455560
Eye (Lond). 2019 Mar;33(3):478-485
pubmed: 30356129
Lancet Neurol. 2006 May;5(5):433-42
pubmed: 16632314
Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1396-403
pubmed: 26499350
Neurology. 1997 Aug;49(2):507-11
pubmed: 9270586
N Engl J Med. 2007 Aug 23;357(8):741-52
pubmed: 17715408
Acta Neurol Scand. 2007 Nov;116(5):322-7
pubmed: 17922725
JAMA Neurol. 2021 Jun 1;78(6):678-686
pubmed: 33900360
Curr Treat Options Neurol. 2011 Feb;13(1):101-8
pubmed: 21063921
Br J Neurosurg. 2020 Feb;34(1):9-12
pubmed: 31805794